Transarterial chemoembolization (TACE) plus apatinib vs. TACE alone for hepatocellular carcinoma

Clinics and Research in Hepatology and Gastroenterology（2022）

引用 3|浏览1

暂无评分

摘要

•TACE plus apatinib increased overall response than TACE.•TACE plus apatinib elevated PFS but not OS than TACE.•TACE plus apatinib did not affect liver function indexes.•TACE plus apatinib increased HFSR incidence but not other AEs than TACE.

查看译文

关键词

Hepatocellular carcinoma,Transarterial chemoembolization,Apatinib,Therapeutic efficacy,Safety profile

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要